RESOURCE LIBRARY

Explore our dedicated Knowledge base

Check out the latest insights, tools and activities to inform your treatment approach for horses with arthritis.

Resources to share with horse owners

Get materials to share with your clients to help them learn about early indicators of arthritis and support your treatment recommendation to help keep their horse moving.

CLIENT
QUESTIONNAIRE:

Lameness Evaluation

Give clients this questionnaire to help gather information about lameness issues so you can better identify and address arthritis early.

DOWNLOAD NOW

DOSING
SCHEDULE:

Stay on Track with 1 • 4 • 7 Dosing

Help clients keep their horses on schedule to receive Adequan i.m. (polysulfated glycosaminoglycan) at the right intervals to achieve optimal results.

DOWNLOAD NOW

DIGITAL
BROCHURE:

Adequan i.m. Horse Owner Brochure

Educate horse owners on the importance of addressing arthritis early, FDA approval, and adhering to the recommend dosing schedule.

DOWNLOAD NOW

DISCUSSION
RESOURCE:

Product Options Brochure

Use this to guide conversations with your clients about why you recommend Adequan i.m. as part of their horse’s treatment plan.

DOWNLOAD NOW

EDUCATION
RESOURCE:

Joint Disease Education Card

Help clients understand the details of equine arthritis and how Adquan i.m. works to keep joints moving comfortably.

DOWNLOAD NOW

DIGITAL
BROCHURE:

Why 1 • 4 • 7 Dosing? Because it Works.

Help clients learn why 1 • 4 • 7 dosing is the recommended dosing schedule to help keep their horse moving.

DOWNLOAD NOW

Resources for you and your team

Use these tools and resources to enhance your team’s knowledge of equine arthritis and strengthen your ability to diagnose and treat it early.

Technical
Bulletin:

The Importance of Drug Specifications

Specifications establish the set of criteria to which a drug substance or drug product must adhere in order to be considered acceptable for its labeled use.

DOWNLOAD NOW

Technical
Bulletin:

FDA-Approved Drugs vs. Other Treatments

Understand the importance of FDA approval and the difference between FDA-approved pioneer drugs, compounded drugs and medical devices.

DOWNLOAD NOW

Technical
Bulletin:

Extend Every Horse’s Mobility

Arthritis can affect horses at any stage of life and regardless of discipline. See how starting early with Adequan i.m. and staying vigilant can help extend every horse’s mobility.


DOWNLOAD NOW

Treatment
Resource:

DJD Handbook

This special issue of EquiManagement features peer-to-peer insights and provides an in-depth look on all things arthritis, from tips on diagnosis to client communication to farrier partnership to product choices.

DOWNLOAD NOW

RACE-approved online CE courses

Take advantage of our free, fully accredited continuing education courses to keep your license up to date. Select the appropriate button below each course to be taken directly to the site where you can review and complete the CE course, undergo testing validation, and receive your certificate of completion.

REDEFINING DJD DIAGNOSIS:

Refining Treatment and Mastering Client Communication

Learn about the diagnosis, treatment and client communication surrounding equine degenerative joint disease (DJD) with Dr. Rick Mitchell and Dr. Kyla Ortved. They take you through different treatment options and real cases to help you know how to identify and treat degenerative joint disease. (1.0 CE)

VETERINARIANS   NURSE/TECHNICIANS

Adequan i.m vial image

Stock up on Adequan i.m.

Contact a distributor to stock your shelves with Adequan i.m. so you’re ready to start prescribing it for your equine patients with DJD.

CONTACT A DISTRIBUTOR

Stay informed on Adequan i.m.

Be the first to hear about important news and product information.

SIGN UP NOW

INDICATIONS
Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan (PSGAG). Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, click here.